Latest News and Press Releases

Lake City, Colo., July 29, 2025 (GLOBE NEWSWIRE) -- With the national median home price reaching $431,250 as of April 2025—requiring an annual income of at least $114,000 to afford—housing...

HFMA presented its highest achievement award to Intermountain Health Executive Vice President and Chief Strategy Officer Dan Liljenquist.

Bio Usawa announced an agreement with Pacific Environmental Technologies to design, build, and deploy state-of-the-art, modular biomanufacturing units.

WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- Key Highlights The U.S. housing market still needs 367,000 more home listings at a maximum price of $170,000, 416,000 more priced at or below...

WARREN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN). As the biopharma industry faces increasing competition from international markets...

WASHINGTON, March 17, 2025 (GLOBE NEWSWIRE) -- Key Highlights Hispanic Americans experienced the most pronounced homeownership rate increase (+5.8 percentage points or 3.5 million homeowners)...

WASHINGTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Key Highlights Pending home sales in January dropped 4.6%.Compared to one month ago, pending home sales retreated in the Midwest, South and West,...

Bio Usawa, a pioneering biotechnology company dedicated to developing affordable monoclonal antibodies in Africa, appointed Dr. Patrick Lukulay as COO.

CEO of Tevogen Bio, Dr. Saadi addresses short selling and its potential impact on the nation’s health and prosperity. Reaffirms commitment to shareholders.

WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy biotech company. As the biopharma...